141 related articles for article (PubMed ID: 34907644)
1. Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma.
Hirabayashi M; Chambers JK; Kishimoto TE; Nguyen SV; Ishikawa Y; Rimpo K; Nakayama H; Uchida K
Vet Comp Oncol; 2022 Jun; 20(2):465-475. PubMed ID: 34907644
[TBL] [Abstract][Full Text] [Related]
2. mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.
Hirabayashi M; Chambers JK; Tani A; Tomiyasu H; Motegi T; Rimpo K; Nakayama H; Uchida K
Vet Comp Oncol; 2022 Sep; 20(3):587-601. PubMed ID: 35278028
[TBL] [Abstract][Full Text] [Related]
3. A review of histiocytic diseases of dogs and cats.
Moore PF
Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of Nonneoplastic and Neoplastic Histiocytes in Cats and Characterization of a Novel Cell Line Derived From Feline Progressive Histiocytosis.
Hirabayashi M; Chambers JK; Sumi A; Harada K; Haritani M; Omachi T; Kobayashi T; Nakayama H; Uchida K
Vet Pathol; 2020 Nov; 57(6):758-773. PubMed ID: 32885737
[TBL] [Abstract][Full Text] [Related]
5. Histiocytic Diseases.
Moore PF
Vet Clin North Am Small Anim Pract; 2023 Jan; 53(1):121-140. PubMed ID: 36270835
[TBL] [Abstract][Full Text] [Related]
6. Establishment of cell line and in vivo mouse model of canine Langerhans cell histiocytosis.
Son NV; Uchida K; Thongtharb A; Chambers JK; Kishimoto TE; Tomiyasu H; Ohmi A; Tsujimoto H; Nakayama H
Vet Comp Oncol; 2019 Sep; 17(3):345-353. PubMed ID: 30884050
[TBL] [Abstract][Full Text] [Related]
7. [Reactive and neoplastic histiocytic diseases in the dog].
Schwens Ch; Thom N; Moritz A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
[TBL] [Abstract][Full Text] [Related]
8. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
Affolter VK; Moore PF
Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
[TBL] [Abstract][Full Text] [Related]
9. Variations in Histiocytic Differentiation of Cell Lines From Canine Cerebral and Articular Histiocytic Sarcomas.
Thongtharb A; Uchida K; Chambers JK; Nakayama H
Vet Pathol; 2017 May; 54(3):395-404. PubMed ID: 28178429
[TBL] [Abstract][Full Text] [Related]
10. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
[TBL] [Abstract][Full Text] [Related]
11. PTPN11 mutations in canine and human disseminated histiocytic sarcoma.
Hédan B; Rault M; Abadie J; Ulvé R; Botherel N; Devauchelle P; Copie-Bergman C; Cadieu E; Parrens M; Alten J; Zalcman EL; Cario G; Damaj G; Mokhtari K; Le Loarer F; Coulomb-Lhermine A; Derrien T; Hitte C; Bachelot L; Breen M; Gilot D; Blay JY; Donadieu J; André C
Int J Cancer; 2020 Sep; 147(6):1657-1665. PubMed ID: 32212266
[TBL] [Abstract][Full Text] [Related]
12. MUM1/IRF4 immunolabeling of neoplastic Langerhans histiocytes in a putative case of canine Langerhans cell histiocytosis.
Klosowski ML; Hughes KL; Moore AR
Vet Clin Pathol; 2023 Dec; 52(4):670-675. PubMed ID: 37528067
[TBL] [Abstract][Full Text] [Related]
13. Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2.
Ito K; Miyamoto R; Tani H; Kurita S; Kobayashi M; Tamura K; Bonkobara M
J Vet Pharmacol Ther; 2018 Feb; 41(1):e45-e48. PubMed ID: 28833247
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed.
Abadie J; Hédan B; Cadieu E; De Brito C; Devauchelle P; Bourgain C; Parker HG; Vaysse A; Margaritte-Jeannin P; Galibert F; Ostrander EA; André C
J Hered; 2009; 100 Suppl 1():S19-27. PubMed ID: 19531730
[TBL] [Abstract][Full Text] [Related]
15. Histological and Immunohistochemical Features of Normal Histiocytes and Langerhans Cells, and Histiocytic Sarcomas in Four-Toed Hedgehogs (Atelerix albiventris).
Son NV; Chambers JK; Dung LT; Kishimoto TE; Nishimura M; Kita C; Takada Y; Miwa Y; Nakayama H; Uchida K
J Comp Pathol; 2020 Jul; 178():32-40. PubMed ID: 32800106
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of canine SHP2 mutants and anti-tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma.
Tani H; Miyamoto R; Nagashima T; Michishita M; Tamura K; Bonkobara M
Vet Comp Oncol; 2022 Mar; 20(1):109-117. PubMed ID: 34241941
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
18. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous histiocytic sarcoma with E-cadherin expression in a Pembroke Welsh Corgi dog.
Hirako A; Sugiyama A; Sakurai M; Ozaki K; Sakai H; Takeuchi T; Morita T; Moore PF
J Vet Diagn Invest; 2015 Sep; 27(5):589-95. PubMed ID: 26330395
[TBL] [Abstract][Full Text] [Related]
20. Morphology and immunophenotype of canine cutaneous histiocytic tumours with particular emphasis on diagnostic application.
Paździor-Czapula K; Rotkiewicz T; Otrocka-Domagała I; Gesek M; Śmiech A
Vet Res Commun; 2015 Mar; 39(1):7-17. PubMed ID: 25563490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
